Quarterly report pursuant to Section 13 or 15(d)

Nature of Business (Detail Narrative)

v3.24.1.u1
Nature of Business (Detail Narrative) - USD ($)
1 Months Ended 6 Months Ended
Oct. 03, 2023
Feb. 16, 2024
Feb. 29, 2024
Feb. 28, 2023
Aug. 31, 2023
Common stock shares issued     12,387,673   8,091,650
Exercise price     $ 3.82    
Gross proceeds from sale of common stock     $ 1,063,475    
Net loss attributable to shareholders     1,800,000 $ 3,100,000  
Accumulated deficit     $ 47,600,000    
Securities Purchase Agreement [Member]          
Common stock shares issued 889,272 1,444,741      
Pre-funded warrants issued 729,058 113,702      
Common stock shares issued during period 1,618,330 1,558,443      
Offering price per share $ 0.97 $ 2.31      
Sale price per share of warrants 0.9699 2.8875      
Exercise price $ 0.0001 $ 2.185 $ 0.95    
Aggregate common stock shares issued 729,058 54,546 1,119,250    
Net proceeds from offering $ 1,250,000 $ 3,000,000.0      
Gross proceeds from sale of common stock $ 73   $ 1,063,475